EP Patent

EP3770159A1 — Benzoquinolone inhibitor of vmat2

Assigned to Auspex Pharmaceuticals Inc · Expires 2021-01-27 · 5y expired

What this patent protects

The present invention relates to a deuterated benzoquinolone inhibitor of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.

USPTO Abstract

The present invention relates to a deuterated benzoquinolone inhibitor of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: EP3770159A1
Jurisdiction: EP
Classification: —
Expires: 2021-01-27
Drug substance claim: No
Drug product claim: No
Assignee: Auspex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.